News

The Kirby Institute joins our colleagues in Zimbabwe in mourning the loss of Professor James Gita Hakim, a global leader in HIV treatment research and our close research collaborator and friend. He passed away due to complications from ...

The Kirby Institute congratulates Dr Nicholas Medland, who has been named the next President of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). As clinical epidemiologist with the Kirby Institute’s ...

A team of leading Sydney researchers is pioneering the use of a fast genomic sequencing technology to help determine the source of hard-to-trace coronavirus cases. Thanks to cutting-edge ‘Nanopore’ genome sequencing technology, ...

There were 903 new HIV diagnoses in 2019. This represents a decline of 12 per cent over five years. While long term trends suggest HIV is declining in Australia, there was a slight increase in HIV numbers from 2018–2019.   The ...

Professor Gregory Dore from the Kirby Institute at UNSW Sydney has won the prestigious 2020 Eureka Prize for Infectious Diseases Research. Professor Gregory Dore’s world-leading research on antiviral therapy for hepatitis C virus (HCV) ...

New report shows stigma remains high despite access to highly effective treatments. Fewer Australians are seeking testing and treatment for hepatitis C, according to a new report from Burnet and Kirby Institutes monitoring Australia’s ...

It’s been a big week for South Australia. First, the announcement of a six-day lockdown to limit the spread of COVID-19. Then today we heard this lockdown may have not been needed, after a man lied to contact tracers, prompting an ...

This story was originally published by the World Health Organization. The Kirby Institute at UNSW Sydney and the World Health Organization (WHO) have published today a systematic review and meta-analysis of the prevalence and incidence ...

The people at highest risk of getting infected with SARS-CoV-2, the virus that causes COVID-19, are close contacts of infected cases. So tracking these close contacts, and quarantining them so they can’t infect others, is key to ...

A new study has estimated how health workers’ risk of SARS-CoV-2 infection differs from that of the broader community. (SYDNEY, Thursday 12 November, 2020) Australian doctors, nurses and other healthcare workers are nearly three times ...

Only a small proportion of Sydney’s population were infected by SARS-CoV-2 earlier this year, a new report co-led by the Kirby Institute says. Australia’s first population-level antibody study designed to shed light on how many people ...

A clinical trial across 12 countries will test a potential COVID-19 treatment, using antibodies purified from plasma taken from people who have recovered from the disease. Researchers from the Kirby Institute at UNSW Sydney together ...

1.4 million has been awarded to a collaboration between researchers in Indonesia, the United Kingdom and Australia, co-led by the Kirby Institute’s Professor Virginia Wiseman. Whilst medical and healthcare workforce resources have ...

A combined $7.55 million has been awarded to two immunology projects at the Kirby Institute at UNSW Sydney via the Australian Government’s highly competitive Medical Research Future Fund (MRFF) scheme. $6.6 million has been awarded ...

A new publication from researchers at UNSW Sydney advises daily washing of cloth masks to reduce the likelihood of contamination and transmission of viruses like SARS-CoV-2. Cloth masks must be washed daily at high temperatures to be ...

Kirby Institute’s Professor Andrew Lloyd and Associate Professor Garrett Prestage have each received NHMRC Partnership grants of over $1 million, announced yesterday by the Federal Government. The grants will support the delivery of ...

People with asthma will be donning face masks this bushfire season to test whether COVID-19-type coverings can also protect vulnerable lungs from smoke. Respiratory experts at the Woolcock Institute of Medical Research in Sydney along ...

Almost half of gay and bisexual men (GBM) who were using PrEP have stopped using it during the COVID-19 pandemic, according to new research from the Kirby Institute at UNSW Sydney published today in the Journal of Acquired Immune ...